S100A9 and neoplasm: Cancer-associated fibroblasts (CAFs) respond to extracellular S100A4, S100A8, and S100A9 by activating pro-inflammatory and pro-fibrotic signaling pathways, which enhance extracellular matrix remodeling and facilitate tumor invasion (45).